EVESOR: a Phase 1 Trial of Everolimus and Sorafenib
Status:
Unknown status
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
EVESOR multiparameter phase I trial aims at determining the safety of different doses and
dosing schedules of everolimus in combination with sorafenib as well as the recommended doses
& dosing schedules for phase 2 trials in adult patients with advanced solid tumors.